Comparative analysis of enoxaparin versus rivaroxaban in the treatment of cancer associated venous thromboembolism: experience from a tertiary care cancer centre

Comparative analysis of enoxaparin versus rivaroxaban in the treatment of cancer associated venous thromboembolism: experience from a tertiary care cancer centre

Abstract Background Venous Thromboembolism (VTE) in cancer patients is associated with increased mortality and morbidity. While newer data on use of direct oral anticoagulants (DOACs) in treating cancer associated thrombosis (CAT) is promising; its data is still few and inconsistent across literatur...

Full description

Bibliographic Details
Main Authors: Anadil Faqah, Hassan Sheikh, Muhammad Abu Bakar, Fatima Tayyaab, Sahrish Khawaja
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Thrombosis Journal
Subjects:
Anticoagulants
Rivaroxaban
Factor Xa inhibitor
Thrombosis
Low-molecular-weight-heparin
Cancer-associated-thrombosis
Online Access:http://link.springer.com/article/10.1186/s12959-020-00221-2

Internet

http://link.springer.com/article/10.1186/s12959-020-00221-2

Similar Items